Your browser is no longer supported. Please, upgrade your browser.
OPGN OpGen, Inc. monthly Stock Chart
OPGN [NASD]
OpGen, Inc.
Index- P/E- EPS (ttm)-1.30 Insider Own67.89% Shs Outstand22.50M Perf Week8.40%
Market Cap29.02M Forward P/E- EPS next Y-0.52 Insider Trans0.00% Shs Float16.15M Perf Month22.86%
Income-19.50M PEG- EPS next Q-0.19 Inst Own43.60% Short Float5.53% Perf Quarter-11.03%
Sales4.30M P/S6.75 EPS this Y-138.60% Inst Trans-5.02% Short Ratio0.67 Perf Half Y-7.78%
Book/sh0.16 P/B8.06 EPS next Y51.40% ROA-166.20% Target Price2.50 Perf Year-22.75%
Cash/sh0.19 P/C6.75 EPS next 5Y- ROE-354.90% 52W Range0.87 - 4.65 Perf YTD12.17%
Dividend- P/FCF- EPS past 5Y- ROI-164.10% 52W High-72.90% Beta-
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin48.10% 52W Low44.83% ATR0.21
Employees48 Current Ratio1.10 Sales Q/Q-20.00% Oper. Margin- RSI (14)53.26 Volatility20.42% 13.07%
OptionableNo Debt/Eq0.45 EPS Q/Q37.80% Profit Margin- Rel Volume0.34 Prev Close1.29
ShortableYes LT Debt/Eq0.06 EarningsJan 23 AMC Payout- Avg Volume1.33M Price1.26
Recom2.00 SMA204.52% SMA508.99% SMA200-15.00% Volume243,432 Change-2.33%
Jun-29-16Initiated Rodman & Renshaw Buy $2.50
Jan-17-17 08:00AM  OpGen Inc. Third Quarter 2016 Review and Fourth Quarter Earnings Outlook Accesswire -5.15%
Dec-19-16 03:30PM  OpGen Supports Passage of Landmark 21st Century Cures Act to Expedite Development of Solutions for Bacterial Infections GlobeNewswire -7.02%
Dec-16-16 04:23PM  OPGEN INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +14.00%
09:26AM  OpGen Provides ATM Program Update GlobeNewswire
Nov-17-16 01:04PM  OPGEN INC Financials
12:47PM  Heres What The OpGen Inc (OPGN) Merck & Co., Inc. (MRK) Agreement Really Means, And Why Its So Important at Insider Monkey
Nov-16-16 10:01AM  OPGEN INC Files SEC form 8-K, Regulation FD Disclosure
Nov-14-16 05:25PM  OpGen teams with Merck to fight superbugs at bizjournals.com
07:00AM  OpGen Collaborates With Merck to Develop Novel Rapid Diagnostics and Informatics Tools to Combat Antibiotic Resistance GlobeNewswire
06:13AM  OPGEN INC Files SEC form 10-Q, Quarterly Report
Oct-27-16 04:25PM  Large Integrated Health Outcomes Study Reveals Shifting Epidemiology In Drug Resistant Organisms GlobeNewswire -10.85%
Oct-26-16 08:00AM  OpGens Infectious Disease Portfolio Highlighted at IDWeek 2016 GlobeNewswire -5.83%
Oct-25-16 10:50AM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q3, 2016 By the Numbers : October 25, 2016 -22.16%
10:12AM  Edited Transcript of OPGN earnings conference call or presentation 24-Oct-16 8:30pm GMT
Oct-24-16 04:33PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:01PM  OpGen Reports 2016 Third Quarter Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q3 2016 OpGen Inc Earnings Release - After Market Close
Oct-20-16 09:02AM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Oct-19-16 05:10PM  OpGen Announces Date of Third Quarter 2016 Financial Results Conference Call GlobeNewswire
Sep-14-16 05:26PM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Sep-08-16 07:30AM  OpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance Congress GlobeNewswire
Sep-07-16 07:30AM  OpGen to Present at the Rodman & Renshaw 18th Annual Global Investment Conference GlobeNewswire
Sep-02-16 04:38PM  OPGEN INC Files SEC form 8-K, Change in Directors or Principal Officers
Aug-11-16 04:07PM  OPGEN INC Files SEC form 10-Q, Quarterly Report -13.06%
11:23AM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-10-16 03:22PM  Edited Transcript of OPGN earnings conference call or presentation 9-Aug-16 8:30pm GMT +6.73%
Aug-09-16 04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:17PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:02PM  OpGen Reports 2016 Second Quarter Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q2 2016 OpGen Inc Earnings Release - Before Market Open
Aug-08-16 11:26AM  OpGen Announces Completion of the Intermountain Healthcare Retrospective MDRO Health Outcome Study GlobeNewswire
Aug-02-16 08:30AM  OpGen, Inc. Announces Timing for Second Quarter Financial Results and Conference Call GlobeNewswire
Jul-22-16 07:00AM  Why SFHI Could Follow Nintendo, OpGen or Liquidmetal In Unexpected Surge
Jul-20-16 04:12PM  Lack of Market Exposure Bothers Bulls +135.67%
Jul-19-16 01:15PM  Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The Infectious Disease Landscape at Insider Monkey +12.23%
Jun-29-16 07:07AM  Coverage initiated on OpGen by Rodman & Renshaw
Jun-24-16 04:10PM  OPGEN INC Files SEC form 8-K, Change in Directors or Principal Officers
Jun-20-16 12:30PM  OpGen Highlights Strong Performance of Acuitas® Resistome Test at ASM Microbe 2016 GlobeNewswire
Jun-06-16 05:04PM  OPGEN INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements a
12:11PM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
Jun-02-16 08:00AM  OpGen to Present at the 6th Annual LD Micro Invitational Conference Accesswire -5.39%
Jun-01-16 12:30PM  Merck & Co. venture arm backs superbug fighter OpGen in $10.3 million funding round at bizjournals.com -6.18%
May-26-16 09:35AM  Capital Infusions Are More Evidence of a Biotech Turnaround at 24/7 Wall St. -6.58%
May-20-16 04:14PM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; C
10:14AM  OpGen Announces Closing of $10 Million Private Placement GlobeNewswire
May-18-16 06:52AM  Edited Transcript of OPGN earnings conference call or presentation 12-May-16 8:30pm GMT
May-17-16 05:28PM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
09:00AM  OpGen Supports New White House National Microbiome Initiative GlobeNewswire
May-16-16 09:04AM  OPGEN INC Files SEC form 10-Q, Quarterly Report -7.89%
May-13-16 06:03AM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +10.68%
May-12-16 04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:01PM  OpGen Reports 2016 First Quarter Financial Results and Business Update GlobeNewswire
09:14AM  OPGEN INC Files SEC form 8-K, Other Events EDGAR Online
09:01AM  OpGen Announces Pricing of $10 Million Private Placement GlobeNewswire
May-10-16 02:03PM  OpGen, Inc. Announces Timing for First Quarter Financial Results and Conference Call GlobeNewswire
May-04-16 07:30AM  OpGen and District of Columbia Hospital Association Complete First Citywide Quantification of Multidrug-Resistant Organism (MDRO) Prevalence in Washington, D.C.-based Healthcare Facilities GlobeNewswire
May-03-16 04:43PM  OPGEN INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
09:05AM  3 Underfollowed Infectious Disease Stocks That Deserve More Attention at 24/7 Wall St.
May-02-16 04:43PM  OPGEN INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
12:22PM  OpGen Appoints Harry J. D'Andrea to Board of Directors GlobeNewswire
Apr-11-16 07:30AM  New Study Data Show OpGens QuickFISH® Blood Culture Pathogen ID Tests to be Rapid and Cost-Effective, with Utility to Inform Antimicrobial Stewardship Decisions GlobeNewswire +9.22%
Mar-30-16 10:00AM  OpGen Inc Earnings Call scheduled for 10:00 am ET today
07:50AM  OpGen Announces 2015 Fourth Quarter and Full Year Financial Results at noodls
07:46AM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  OpGen Announces 2015 Fourth Quarter and Full Year Financial Results GlobeNewswire
07:07AM  Q4 2015 OpGen Inc Earnings Release - Time Not Supplied
Mar-21-16 07:47AM  OpGen Announces New Members to its Clinical Advisory Board at noodls +14.71%
07:30AM  OpGen Announces New Members to its Clinical Advisory Board GlobeNewswire
Mar-16-16 11:09AM  OpGen, Inc. Announces Timing for 2015 Fourth Quarter and Year End Financial Results and Conference Call GlobeNewswire -8.81%
Feb-03-16 08:00AM  OpGen to Present at Source Capital Groups 2016 Disruptive Growth & Healthcare Conference GlobeNewswire
Jan-13-16 04:00PM  OpGen, Inc., to Present at Noble Financial Capital Markets 12th Annual Investor Conference GlobeNewswire
Jan-12-16 09:21AM  OPGEN INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -5.91%
Dec-17-15 08:30AM  OpGen's QuickFISH Rapid Pathogen ID Test Demonstrates Clinical Utility and Cost Effectiveness in Community Hospitals Antimicrobial Stewardship Program GlobeNewswire
Dec-03-15 11:27AM  OpGen, Inc. Earnings Q3, 2015
Nov-18-15 08:30AM  District of Columbia Hospital Association Chooses OpGen to Create Citywide Effort to Track Multidrug-Resistant Bacteria GlobeNewswire
Nov-13-15 06:04AM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition
Nov-12-15 04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:02PM  OpGen Reports Third Quarter Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q3 2015 OpGen Inc Earnings Release - After Market Close
Nov-04-15 10:00AM  OpGen, Inc. Announces Timing for Third Quarter Financial Results and Conference Call GlobeNewswire
Oct-12-15 08:30AM  Data Show Super Bug Surveillance System Based on OpGens Acuitas(R) Resistome Test Can Identify Potential Outbreaks in Hospitals and Improve Infection Control GlobeNewswire
Sep-28-15 04:34PM  OPGEN INC Files SEC form 8-K/A, Financial Statements and Exhibits
Sep-22-15 08:15AM  OpGen to Present Data Showing Acuitas(R) Tests are Effective Tools for Investigating Transmission of "Super Bugs" GlobeNewswire +6.92%
Aug-14-15 06:35PM  OPGEN INC Files SEC form 10-Q, Quarterly Report -8.46%
11:35AM  Edited Transcript of OPGN earnings conference call or presentation 13-Aug-15 8:30pm GMT
Aug-13-15 04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today +6.67%
04:06PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition
04:02PM  OpGen Reports Second Quarter Financial Results and Provides Business Update GlobeNewswire
Aug-05-15 11:05AM  OpGen, Inc. Announces Timing for Second Quarter Financial Results and Conference Call GlobeNewswire
Jul-16-15 07:53AM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation o
Jul-14-15 09:05AM  OpGen Closes $6 Million Financing With Merck GHI to Expand Infectious Disease Diagnostic Testing Capabilities GlobeNewswire +6.60%
09:01AM  OpGen to Acquire AdvanDx, Inc. GlobeNewswire
Jul-13-15 12:00PM  Fluidigm and OpGen Enter Into Strategic Agreement to Develop Multi-Drug Resistance Testing Kits and Equipment GlobeNewswire +10.50%
12:00PM  Fluidigm and OpGen Enter into Strategic Agreement to Develop Multi-Drug Resistance Testing Kits and Equipment Business Wire
Jun-17-15 04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:05PM  OpGen Reports First Quarter Financial Results and Provides Business Update GlobeNewswire
Jun-11-15 12:01PM  OpGen, Inc. Announces Timing for First Quarter Financial Results and Conference Call GlobeNewswire
Jun-02-15 06:05AM  OpGen Releases Next-Generation Molecular Testing and Bioinformatics Solution for Combating Multi-Drug Resistant Infections GlobeNewswire +6.80%
May-27-15 07:30AM  OpGen's Acuitas(R) MDRO Gene Tests and Bioinformatics Data to be Presented at ASM2015 GlobeNewswire
OpGen, Inc. engages in developing and deploying precision medicine tools to combat infectious disease in global healthcare settings. It helps physicians enhance patient outcomes by providing information about life-threatening infections and decreasing the spread of infections caused by multidrug-resistant microorganisms. The company offers a portfolio of in vitro diagnostic products and clinical laboratory services that employ molecular diagnostics and bioinformatics. Its QuickFISH products are a suite of FDA-cleared and CE-marked diagnostics used to detect pathogens in positive blood cultures. The company provides Acuitas MDRO gene test to identify the presence of antibiotic resistant genes for high-risk patients quickly and with high sensitivity and specificity; and Acuitas Lighthouse MDRO management system, which offers epidemiological typing, tracking, and trending to inform infection control, surveillance, and antibiotic stewardship decision makers. In addition, it offers Acuitas whole genome sequence analysis for transmission investigations and epidemiology research. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.